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                    Dear  Sir: 
  Bryce and Steketee’s interest in integrated continuous sur-
veys and quality management  1   (I-Q) is appreciated, especially 
because they emphasize its dual potential to strengthen pro-
grams and improve monitoring and evaluation systems. They 
raise several important positive points regarding the flexibil-
ity of continuous surveys, the use of time-series analyses to 
evaluate real-world programs in which public health activities 
cannot be neatly grouped into intervention and control areas, 
and the ability of I-Q to address the gap between data, quality, 
and action at the national and local level. They also raise sev-
eral important concerns, such as the challenge of creating and 
maintaining the continuous survey teams, the requirement of a 
critical mass of supporters and long-term commitment of gov-
ernment leaders and donors, and the risk involved in under-
taking such a complex and ambitious strategy. 
  Although all these concerns are relevant, perhaps the most 
important is risk. Worries about failure or making a situa-
tion worse are natural and healthy; however, they can pre-
vent or delay discoveries of genuinely successful innovations. 
As Bryce and Stetekee suggest, it is understandable that I-Q 
could be perceived as being risky because it involves chang-
ing parts of the health system to fully implement quality man-
agement principles and altering the well-accepted paradigm of 
periodic cross-sectional household surveys. When considering 
whether to risk an intervention with potentially far-reaching 
consequences, one might ask: are we content with the status 
quo? In countries with increased resources, are interventions 
being scaled-up as quickly and equitably as desired? Are exist-
ing monitoring and evaluation systems efficiently providing 
the needed information on coverage and impact to programs 
and donors? On this last question, consider the example of one 
country, in which five nationwide, cross-sectional household 
surveys were conducted in a 12-month period.  2   Altogether 
these surveys collected data from nearly 35,000 households 
(about five times larger than a typical Demographic and 
Health Survey  3  ); and although each survey lasted 1–5 months, 
data collection occurred in every month of the 12-month 
period—essentially continuous data collection. Other similar 
examples exist. 
  Of course, the middle path that balances the risks of fail-
ure and missing a successful innovation involves starting with 
a sub-national pilot project, retaining any existing plans for 
conventional cross-sectional surveys, and evaluating the pilot 
experience carefully before deciding whether to scale-up. In 
such a pilot study of I-Q, four recommendations should be con-
sidered. First, test the entire concept: do not only implement 
continuous surveys without the quality management compo-
nent. While continuous surveys might have some advantages 
over periodic cross-sectional surveys, the flow of so much data 
without improved structures to use the results is potentially 
wasteful, and such an approach does not truly test the I-Q 
concept. Similarly, health facility surveys should be included, 
as they can provide valuable information on the quality of 
care and availability of commodities over time. For example, 
health facility surveys on malaria in low-income African coun-
tries revealed that despite reasonably well-designed efforts to 
implement new policies on testing and treatment, underuse of 
malaria testing was common, negative test results were often 
ignored, and many patients needing antimalarial therapy did 
not receive it.     4–10 
  The second recommendation is to test the concept in a rea-
sonably large geographic area, perhaps at least 10 districts. 
A test in only a few districts will make the surveys seem dispro-
portionately expensive (in terms of cost per population size) 
and overly precise (surveys could produce sub-district results, 
which would not be feasible if I-Q was scaled-up nationally). 
Furthermore, the challenge of implementing quality manage-
ment principles might not be fully experienced in small areas 
because distances are short, populations more likely to be sim-
ilar, and everything is logistically easier  . The third recommen-
dation is to let a pilot study continue long enough to allow 
for a full evaluation, perhaps at least 5 years. As Bryce and 
Steketee rightly point out, it will take time to establish the 
continuous survey teams and quality management structures. 
Finally, adequate funding is essential to ensure a sufficient 
number of survey teams, robust quality management struc-
tures, and resources for quality improvement teams to imple-
ment changes. It would be better to test a fully funded I-Q 
project that was successful and then think of ways to reduce 
costs than to have an underfunded pilot that does not realize 
its potential. 
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